Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Clinicians urge review of the cardiotoxicity of trastuzumab

July 31, 2000

VRCTC-310-Onco enhances serum antiinflammatory cytokine production in humans

July 28, 2000

New allogeneic cancer vaccines in development at Onyvax

July 25, 2000

Genentech acquires rights to PSCA from UroGenesys

July 21, 2000

M-Vax now available in Australia for melanoma therapy

July 20, 2000

Maxim submits NDA for Maxamine

July 20, 2000

Joint venture for OvaRex initiated by AltaRex in Middle East

July 14, 2000

Antisoma resumes enrollment in SMART phase III trial

July 14, 2000

Chiron reports new durable response data for Proleukin

July 13, 2000

KS Biomedix seeks approval to begin clinical trials of anticancer antibody

July 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...